Diabetic Medications That Cause Leg Swelling
Many different types of oral medications help treat type II diabetes, and some may produce side effects such as swelling. If your legs swell when you take diabetes medications, call your doctor. He may need to change medicines. The only medication for people with type I diabetes is insulin, which does not produce swelling.
If you are experiencing serious medical symptoms, seek emergency treatment immediately.
Rosiglitazone
Rosiglitazone may cause swelling in your body, as well as weight gain, according to Drugs.com 5. Before starting this diabetic medication, inform your doctor if you have a history of heart problems. Drugs.com says that rosiglitazone may raise the level of risk of heart attacks 5. For this reason, your doctor only should prescribe it if other diabetic drugs do not work for you.
Metformin
Alternatives for Januvia
Learn More
Metformin, often the first medication your doctor will prescribe for Type II diabetes, helps to control glucose levels by restricting how much sugar your body absorbs. It also helps your liver and cells to become more sensitive to the insulin your pancreas secretes so your body can use glucose more effectively. Metformin may cause swelling in your body, including your legs, according to the Mayo Clinic.
Metformin and Pioglitazone Combination
Your physician may prescribe a drug for your Type II diabetes that contains a combination of metformin and pioglitazone that may produce swelling in your legs, according to the Mayo Clinics 2. Pioglitazone works by making the appropriate parts of your body -- such as the muscle cells, fat cells and liver -- use insulin more effectively. Together, these two medications in one pill may cause swelling in your body and weight gain, according to Drugs.com 5. If swelling occurs, it may reduce the circulation of blood in your body, so your doctor may need to switch medications. Talk with your doctor if you have a history of heart or kidney disease.
Exenatide
Metformin vs. Januvia for Weight Loss
Learn More
Exenatide may cause you to lose weight. However, the medication may cause weight gain, as well as swelling in your body -- including your legs. The swelling side effect may occur in different ways. Talk with your doctor if you notice any weight changes, as well as swelling.
- Exenatide may cause you to lose weight.
- However, the medication may cause weight gain, as well as swelling in your body -- including your legs.
Related Articles
References
- MayoClinic.com: Pioglitazone and Metformin (Oral Route)
- Drugs.com: Actoplus Met
- MedlinePlus: Diabetes
- Drugs.com: Glucophage
- MayoClinic.com: Byetta
- Nasri H, Rafieian-Kopaei M. Metformin: current knowledge. J Res Med Sci. 2014;19(7):658–664.
- American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Suppl 1):S98-S110. doi:10.2337/dc20-S009
- U.S. Food and Drug Administration. Glucophage and Glucophage XR.
- Corcoran C, Jacobs TF. Metformin. In: StatPearls [Internet]. 2020.
- Maruthur NM, Tseng E, Hutfless S, et al. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: A systematic review and meta-analysis. Ann Intern Med. 2016;164(11):740-51. doi:10.7326/M15-2650
- Doyle-Delgado K et al. Pharmacologic approaches to glycemic treatment of type 2 diabetes: Synopsis of the 2020 American Diabetes Association's standards of medical care in diabetes clinical guideline. Ann Intern Med 2020 Sep 1; [e-pub].
- Lei Y, Yi Y, Liu Y, et al. Metformin targets multiple signaling pathways in cancer. Chin J Cancer. 2017;36(1):17. doi:10.1186/s40880-017-0184-9
- Meng X, Xu S, Chen G, Derwahl M, Liu C. Metformin and thyroid disease. J Endocrinol. 2017;233(1):R43-R51. doi:10.1530/JOE-16-0450
- Beysel S, Unsal IO, Kizilgul M, Caliskan M, Ucan B, Cakal E. The effects of metformin in type 1 diabetes mellitus. BMC Endocr Disord. 2018;18(1):1. doi:10.1186/s12902-017-0228-9
- Kanto K, Ito H, Noso S, et al. Effects of dosage and dosing frequency on the efficacy and safety of high-dose metformin in Japanese patients with type 2 diabetes mellitus. J Diabetes Investig. 2017;9(3):587–593. doi:10.1111/jdi.12755
- Kalra S, Mukherjee JJ, Venkataraman S, et al. Hypoglycemia: the neglected complication. Indian J Endocrinol Metab. 2013;17(5):819–834. doi:10.4103/2230-8210.117219
- Wang YW, He SJ, Feng X, et al. Metformin: a review of its potential indications. Drug Des Devel Ther. 2017;11:2421–2429. doi:10.2147/DDDT.S141675
- Kraut JA, Madias NE. Lactic acidosis: current treatments and future directions. Am J Kidney Dis. 2016;68(3):473-82. doi:10.1053/j.ajkd.2016.04.020
- Chapman LE, Darling AL, Brown JE. Association between metformin and vitamin B deficiency in patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab. 2016;42(5):316-327. doi:10.1016/j.diabet.2016.03.008
- Pakkir Maideen NM, Jumale A, Balasubramaniam R. Drug interactions of metformin involving drug transporter proteins. Adv Pharm Bull. 2017;7(4):501–505. doi:10.15171/apb.2017.062
- Kasper DL, Fauci AS, Hauser SL. Harrison's principles of internal medicine. New York: McGraw-Hill Education, 2015. Print.
- Lalau JD, Kajbaf F, Protti A, et al. Metformin-associated lactic acidosis (MALA): Moving towards a new paradigm. Diabetes Obes Metab. 2017;19(11):1502-1512. doi:10.1111/dom.12974
- Thomas I, Gregg B. Metformin: A review of its history and future: From lilac to longevity. Pediatr Diabetes. 2017;18(1):10-16. doi:10.1111/pedi.12473
Writer Bio
Carole Anne Tomlinson is a registered nurse with experience in rehabilitation, nutrition, chemical dependency, diabetes and health problems related to the elderly. Tomlinson holds a Bachelor of Arts in criminal justice and is presently working on her master's degree in nursing. Her screenplays have been viewed by Merchant Ivory, Angela Lansbury and Steven King's associates.